Pfizer, Ranbaxy Look To Dump State Claims In Lipitor MDL

By Chuck Stanley · April 17, 2018, 7:47 PM EDT

Pfizer Inc. and generic-drug maker Ranbaxy Inc. asked a New Jersey federal court Monday to quash state law claims in multidistrict litigation from a group of Lipitor buyers that say the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Judgment on the Pleadings

Case Information

Case Title

BURLINGTON DRUG CO., INC. et al v. PFIZER INC. et al

Case Number

Court

New Jersey

Nature of Suit

Anti-Trust

Date Filed

April 23, 2012

Recent Articles By Chuck

October 26, 2018
Too Late To Stop Bargain Bin Health Plans, Judge Says
October 23, 2018
Couple Says Gov't 'Ambush' Led To Fraud Convictions
October 04, 2018
Athena Asks Fed. Circ. To Revive Nixed Biotech Patent
August 16, 2018
Antitrust Suit Against Walgreens, Benefits Manager Tossed
August 13, 2018
Fed. Circ. Wrong On HIV Drug Patent Challenge, Justices Hear
August 06, 2018
Dental Cos. Look to Straighten Patent Row In Fed. Circ.
July 11, 2018
FCC Announces $100M Telehealth Pilot Program
June 14, 2018
Aggrenox Buyers Slam Insurers' Bid To Opt Health Plans Out
June 13, 2018
BCBS Can Appeal Ruling That Limits Antitrust MDL Defense
May 24, 2018
Teledentistry Co. Hits Ga. Dentistry Board With Antitrust Suit